Building Your Care Team: Preparing for Your Journey
At a Glance
The best diabetic macular edema care connects a retina specialist with clinicians who manage diabetes, blood pressure, cholesterol, and kidney health. Bring eye scans, treatment records, lab results, and a medication list so your team can coordinate decisions.
Treating Diabetic Macular Edema (DME) is a collaborative effort between you and a specialized team of medical professionals. Because DME is an eye-level symptom of a body-wide condition, your success depends on how well your “eye team” and your “diabetes team” communicate [1][2].
Your Supportive Care Team
An integrated approach helps ensure that while your eyes are being treated directly, the underlying factors—like high blood sugar and blood pressure—are also being addressed [3][4].
- Retina Specialist: This is an ophthalmologist who has completed additional training in diseases of the vitreous and retina. They are the “lead” for your DME care, performing injections, interpreting your OCT scans, and administering laser therapy if needed [5].
- Endocrinologist or Primary Care Physician: They manage your systemic health. Their goal is to help you reach individualized HbA1c, blood pressure, and cholesterol targets, which can help slow the progression of microvascular damage [6][7].
- Nephrologist (Kidney Specialist): Because blood vessels in the eye and kidneys are similar, people with diabetic eye disease often share risk factors for kidney disease [8]. While primary care doctors can manage early kidney issues, a nephrologist may be consulted if there is persistent protein in your urine (albuminuria) or declining function (eGFR) [9][2].
- Diabetes Educator/Dietitian: These professionals provide practical tools for managing nutrition and lifestyle, which are the foundations of long-term diabetes management [6].
Discussing Options with Your Specialist
When managing a chronic condition like DME, you are entering a long-term relationship with your eye clinic. You should feel empowered to discuss the rationale behind your treatment plan. Consider asking:
- Treatment Flexibility: Ask how they decide on the timing of injections—whether they use a fixed schedule or adjust the intervals based on how your eye responds [10].
- Evaluating Progress: If your retina doesn’t “dry out” sufficiently after several injections, discuss what alternative options (like different medications or steroids) might be appropriate for your specific case [5][11].
Preparing for Your Visit
To get the most out of your appointments and ensure your specialist has a complete picture of your health, consider bringing the following “artifacts” to every major visit:
- Imaging and Injection History: If you are moving from another clinic, try to bring your previous OCT scan files (not just the paper summaries) and a log of exactly which drugs you were given and when [12][13].
- Recent Lab Results: Your most recent HbA1c trend, blood pressure logs, and kidney function markers [14][15].
- Medication List: Include all vitamins and supplements, as some can interact with your overall diabetes management [16].
The Benefits of Integrated Care
Patients who receive care through a coordinated system—where specialists share standardized reports—often navigate the disease more effectively [17][18]. While treating your eyes does not directly treat your kidneys or heart, the conditions share the same microvascular risk factors. By ensuring your care team communicates, you maximize the impact of your efforts, keeping your whole body—and your vision—as healthy as possible.
Common questions in this guide
Which specialists should be part of my diabetic macular edema care team?
What should I bring to a diabetic macular edema appointment?
How does my specialist decide when I need another DME injection?
What happens if injections do not dry my retina enough?
Why should my eye doctor communicate with my diabetes doctor?
Get notified when new evidence is published on diabetic macular edema.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Considerations for management of patients with diabetic macular edema: Optimizing treatment outcomes and minimizing safety concerns through interdisciplinary collaboration.
Strain WD, Cos X, Prünte C
Diabetes research and clinical practice 2017; (126()):1-9 doi:10.1016/j.diabres.2017.01.013.
PMID: 28189948 - 2
General health of patients with diabetic macular edema-The LIPSIA study.
Busch C, Katzmann JL, Jochmann C, et al.
PloS one 2021; (16(6)):e0252321 doi:10.1371/journal.pone.0252321.
PMID: 34115786 - 3
[Anti-VEGF therapy for diabetic retinopathy].
Chekhonin ES, Fayzrakhmanov RR, Sukhanova AV, Bosov ED
Vestnik oftalmologii 2021; (137(4)):136-142 doi:10.17116/oftalma2021137041136.
PMID: 34410069 - 4
Diabetic Disease of the Eye in Canada: Consensus Statements from a Retina Specialist Working Group.
Omar A, Williams RG, Whelan J, et al.
Ophthalmology and therapy 2024; (13(5)):1071-1102 doi:10.1007/s40123-024-00923-0.
PMID: 38526804 - 5
Management of diabetic macular edema: experts' consensus in Taiwan.
Chen JT, Chen LJ, Chen SN, et al.
Japanese journal of ophthalmology 2020; (64(3)):235-242 doi:10.1007/s10384-020-00741-4.
PMID: 32342244 - 6
Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease.
Gale R, Scanlon PH, Evans M, et al.
Eye (London, England) 2017; (31(S1)):S1-S20 doi:10.1038/eye.2017.53.
PMID: 28490797 - 7
Diabetic retinopathy.
Wong TY, Cheung CM, Larsen M, et al.
Nature reviews. Disease primers 2016; (2()):16012 doi:10.1038/nrdp.2016.12.
PMID: 27159554 - 8
Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease.
Ou SH, Chang WC, Wu LY, et al.
The Journal of clinical endocrinology and metabolism 2024; (109(3)):761-770 doi:10.1210/clinem/dgad581.
PMID: 37804118 - 9
Interrelationship of diabetic neuropathy, retinopathy and nephropathy in type 2 diabetes mellitus: a cross-sectional analysis.
Roostaei S, Ashraf A, Fard MV, Johari M
BMC ophthalmology 2025; (25(1)):604 doi:10.1186/s12886-025-04470-5.
PMID: 41162884 - 10
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, et al.
Ophthalmology 2024; (131(6)):708-723 doi:10.1016/j.ophtha.2023.12.026.
PMID: 38158159 - 11
Switching to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular edema: a systematic review and meta-analysis.
Tahmasebi A, Ebrahimiadib N, Niyousha M, Hassanpoor N
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2025; (263(10)):2693-2707 doi:10.1007/s00417-025-06878-7.
PMID: 40571775 - 12
[Diabetic Macular Edema].
Barth T, Helbig H
Klinische Monatsblatter fur Augenheilkunde 2021; (238(9)):1029-1043 doi:10.1055/a-1545-9656.
PMID: 34380156 - 13
Evaluation of markers of outcome in real-world treatment of diabetic macular edema.
Campos A, Campos EJ, do Carmo A, et al.
Eye and vision (London, England) 2018; (5()):27 doi:10.1186/s40662-018-0119-9.
PMID: 30386806 - 14
Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes.
Graue-Hernandez EO, Rivera-De-La-Parra D, Hernandez-Jimenez S, et al.
BMJ open ophthalmology 2020; (5(1)):e000304 doi:10.1136/bmjophth-2019-000304.
PMID: 32201732 - 15
Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
Debourdeau E, Medard R, Chamard C, et al.
Ophthalmology and therapy 2023; (12(5)):2657-2670 doi:10.1007/s40123-023-00758-1.
PMID: 37505396 - 16
The prevalence and systemic risk factors of diabetic macular edema: a cross-sectional study from Turkey.
Acan D, Calan M, Er D, et al.
BMC ophthalmology 2018; (18(1)):91 doi:10.1186/s12886-018-0753-y.
PMID: 29649995 - 17
Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Wong TY, Sun J, Kawasaki R, et al.
Ophthalmology 2018; (125(10)):1608-1622 doi:10.1016/j.ophtha.2018.04.007.
PMID: 29776671 - 18
Diabetic macular edema.
Ixcamey M, Palma C
Disease-a-month : DM 2021; (67(5)):101138 doi:10.1016/j.disamonth.2021.101138.
PMID: 33581844
This page is for informational purposes only and does not constitute medical advice. Your retina specialist and diabetes care team should guide decisions about DME treatment and monitoring.